Science and technology in Russia

Russia’s space agency Roscosmos said in a statement that a memorandum was signed between the two countries

Russia is pushing ahead with plans to make its Covid-19 vaccine in Europe, securing a deal to produce the Sputnik V shot in Italy and discussing production in Germany and France.

Adienne Pharma & Biotech SA signed an agreement to manufacture the vaccine at its production site in the Milan region, founder and President Antonio Francesco Di Naro told Bloomberg in an interview

The creators of the Russian vaccine "Sputnik V" demand an apology from the chairman of the European Medicines Agency (EMA) Christa Virtumer-Hohe, who compared the prospect of an emergency approval of the Russian vaccine in Austria, following the example of Hungary, to "Russian roulette".

The European Medicines Agency (EMA) on Thursday (4 March) began a rolling review of Russia's Sputnik V vaccine in a first step towards granting the approval of the jab across the EU.

The agency's human medicines committee (CHMP) said it would review Sputnik V, a COVID-19 vaccine developed by Russia's Gamaleya national centre of epidemiology and microbiology.

"We shouldn't count chickens before they are hatched," Health Minister Kostadin Angelov told journalists in Varna, where he is on a visit today admitting of the chaos in the vaccination campaign.

"I can't take any commitments because the result does not depend on us," he said.

However, the Croatian authorities have not yet sent an official request for the purchase of Sputnik V, Vecernji list writes today.
The paper states that the Russian embassy is "under siege" by Croats and that it answers dozens and dozens of questions from Croatian citizens sent by phone or e-mail every day about how to get the Russian vaccine.

Just to reiterate that the European Commission practically nailed the position of Brussels on the issue of the Russian vaccine, by announcing that the vaccine is not part of the EU vaccination strategy, nor is it discussing its inclusion in the strategy with its producers.

It is added that the Russian manufacturer of the vaccine Sputnik V is in contact with the European Medicines Agency regarding the evaluation of this vaccine. "The EU has a market for vaccines that is subject to strict conditions, and to which vaccines can come, no matter where they come from, as long as they meet the criteria.

Vui said that 50.000 doses of the Russian vaccine against the coronavirus Sputnik V arrived at the Belgrade airport this morning, and that more Pfizer vaccines and AstraZeneca vaccines will arrive by the end of February.

On the verge of a third wave of mutant strains of Covid-19 and problems with the supply of agreed vaccines, the European Union reports a serious problem with the vaccination of the population and already mulls purchasing other vaccines - the Russian Sputnik V and the Chinese Sinopharm.